Western Drugs Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 22-11-2024
- Paid Up Capital ₹ 4.15 Cr
as on 22-11-2024
- Company Age 35 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 74.00 Cr
as on 22-11-2024
- Satisfied Charges ₹ 40.00 Cr
as on 22-11-2024
- Revenue -2.81%
(FY 2024)
- Profit 251.20%
(FY 2024)
- Ebitda 317.18%
(FY 2024)
- Net Worth 8.63%
(FY 2024)
- Total Assets 32.25%
(FY 2024)
About Western Drugs
The Corporate was formerly known as Western Drugs Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 4.15 Cr.
The company currently has active open charges totaling ₹74.00 Cr. The company has closed loans amounting to ₹40.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Mishri Lodha, Bhagwati Dagliya, Mahavir Ranka, and Four other members serve as directors at the Company.
- CIN/LLPIN
U24232RJ1989PLC004914
- Company No.
004914
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
20 Apr 1989
- Date of AGM
16 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
Company Details
- Location
Udaipur, Rajasthan, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Western Drugs Limited offer?
Western Drugs Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Nutritional Supplements, ISO & Quality Management Consultants, Certification Services, Pharma Ingredients & Raw Materials, Vitamin Powder API, Multivitamin Tablets & Capsules.
Who are the key members and board of directors at Western Drugs?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bhagwati Dagliya  | Managing Director | 20-Apr-1989 | Current |
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Mishri Lodha | Whole-Time Director | 20-Apr-1989 | Current |
| Mahavir Ranka | Whole-Time Director | 27-Mar-1991 | Current |
| Dilip Ranka | Whole-Time Director | 02-Mar-2015 | Current |
| Jayantilal Ranka | Director | 18-Apr-2016 | Current |
| Neha Bapna | Director | 03-Feb-2020 | Current |
| Ankita Agrawal | Director | 16-Sep-2024 | Current |
Financial Performance and Corporate Structure Insights of Western Drugs.
Western Drugs Limited, for the financial year ended 2024, experienced Minor drop in revenue, with a 2.81% decrease. The company also saw a substantial improvement in profitability, with a 251.2% increase in profit. The company's net worth moved up by a moderate rise of 8.63%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Western Drugs?
In 2024, Western Drugs had a promoter holding of 26.72% and a public holding of 73.28%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ranka Organics Private LimitedActive 26 years 4 monthsMishri Lodha, Bhagwati Dagliya and 2 more are mutual person
- Transmissions Limited Liability Partners HipActive 11 years 7 months
Jayantilal Ranka is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 10 Oct 2022 | ₹4.50 Cr | Open |
Citi Bank N.A. Creation Date: 23 Feb 2005 | ₹38.00 Cr | Open |
Citi Bank N.A. Creation Date: 30 Dec 2004 | ₹31.50 Cr | Open |
How Many Employees Work at Western Drugs?
Western Drugs has a workforce of 196 employees as of Nov 22, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Western Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Western Drugs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
